MTTP and metabolic dysfunction-associated steatotic liver disease: Given the effect of PPARα on lipoprotein metabolism, it could be speculated that declining PPARα levels with NAFLD progression [75, 86] contribute to lower MTTP levels and apoB100 secretion rates.